BRTX vs EFX · rev $401.0K vs P/E 54, rev $5.68B
BioRestorative Therapies Inc (BRTX) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
BRTX currently screens at market cap $10.2M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the BRTX and EFX stock pages for the full models.
Not investment advice.